Our Blog

Merck agrees to settle NuvaRing cases for $100 million

February 10, 2014 | By John Feroleto

The drug company Merck will pay $100 million to resolve lawsuits of women involving the NuvaRing contraceptive. NuvaRing may well put woman at a greater risk of blood clots, and stroke than other birth control methods. As an attorney who handles defective and dangerous product cases,the evidence in these cases looked very solid. Merck has added new warnings to the package labeling.

Like other hormonal methods, NuvaRing comes with a potential side effect of blood clot risks. The risk includes getting a venous thrombosis, or VTE that forms in the deep veins, often the legs. If the clot breaks off and moves to the lungs it is called a pulmonary embolism and is very often fatal. Thursday, the American Heart Association published guidelines recommending woman considering oral contraceptives to get screened for high blood pressure is the pills can increase the risk of blood clots and stroke.

Request Your Free Consultation

Get the answers and support you need. Our friendly and experienced Buffalo personal injury lawyers will take the time to understand your case, explain your options, and guide you every step of the way.

First Name *

Last Name *

Phone Number *

Email *

Message *

"I think John is the tops! He always treated me like a mother. He took a while to get everything in order and he got it all done. He handled an impossible case, just let me put it that way."

Irene

Our Blog

Read More Articles

© 2025 All Rights Reserved – Referring Attorneys | Feroleto Law, Buffalo NY Attorneys | Attorney Advertising. Past results do not guarantee future outcomes.